Testing effectiveness (Phase 2)Study completedNCT06440187
What this trial is testing
Nivolumab Plus Gemcitabine in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma-HN17-11
Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinom
Seoul National University Hospital 38